gdc
SarcomaSlideshowsWeb Exclusives

Did You Know? Sarcoma Facts

Take a cruise through this Sarcoma slideshow to learn about this uncommon but underdiagnosed type of malignancy.
Web Exclusives – July 18, 2017
  • Slideshow Soft Tissue Sarcomas 1

    Approximately 30% of skeletal system cancers are chondrosarcomas.

    Source: Cancer.net
  • DidYouKnow Horizontal BrickWall

    Approximately 50% of soft-tissue sarcomas develop in an arm or leg; 40% develop in the torso or abdomen; and 10% develop in the head or neck.

    Source: Cancer.net
  • Slideshow Soft Tissue Sarcomas 3

    Soft-tissue sarcomas can be difficult to distinguish from other malignancies when they are found within organs, leading experts to believe soft-tissue sarcomas are under-reported.

    Source: Cancer.net
  • Slideshow Soft Tissue Sarcomas 5

    Sarcomas are more commonly diagnosed in children than adults, as they account for approximately 1% of all adult cancers and 15% of all childhood cancers.

    Source: Journal of Orthopedic Oncology
  • Slideshow Soft Tissue Sarcomas

    Soft-tissue sarcomas rarely cause symptoms in early stages. Because soft-tissue sarcomas can develop in flexible, elastic tissues or deep spaces in the body, the tumors may grow quite large before they cause symptoms.

    Source: Cancer.net
  • Slideshow Soft Tissue Sarcomas 6

    Want to learn more about sarcomas? Click here to check out our articles on this topic.

Recommended For You
Web Exclusives
How Sharing Your Cancer Story Can Have a Positive Impact
Having the courage to speak up and reach out to others who are going through a similar experience give patients with cancer the opportunity to achieve a positive change in their well-being.
SarcomaSlideshowsWeb Exclusives
July is Sarcoma/Bone Cancer Awareness Month!
Learn some quick facts, most common types, and signs and symptoms of bone cancer and sarcoma in this slideshow.
LeukemiaNewsworthyWeb Exclusives
Quizartinib Significantly Improves Survival Over Chemotherapy in Patients with Relapsed/Refractory AML and FLT3-ITD Mutation
This is the first treatment that targets patients with AML and the FLT3-ITD mutation. In this clinical trial, patients who received quizartinib lived longer without disease progression than those receiving chemotherapy.
Skin CancerSlideshowsWeb Exclusives
Skin Cancer Awareness Month
May is Skin Cancer Awareness Month! View this slideshow to learn the latest statistics in the United States, leading causes and preventive measures, and quick facts on melanoma, one of the most common types of skin cancer. Conquer cancer with knowledge.
Last modified: October 5, 2017

Subscribe to CONQUER: the patient voice® magazine

Receive timely cancer news & updates, patient stories, and more.

Country